en

PRODUCT DETAIL

Paxlovid 150 mg + 100 mg filmom obalené tablety

Code 9547D
MA number EU/1/22/1625/001
Product Form: tbl flm 30 (20x150 mg+10x100 mg) (blis.OPA/Al/PVC)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK)
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AE Protease inhibitors
J05AE30 nirmatrelvir and ritonavir
Shelf life: 24
Container: blister OPA/Al/PVC
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 28.01.2022
Validity: 24.02.2028
SmPC + PL: European Medicines Agency's database
Dokument: infolist_Paxlovid_Shelf Life extension_24 mes_ dalsie sarze_04-10-2023.pdf  
Dokument: DHPC_Paxlovid_21.03.2024.pdf  
Safety feature Unknown
Data update: 01.03.2023
eu-flag.png sk-flag.png